488 related articles for article (PubMed ID: 32889579)
1. Azole derivatives with naphthalene showing potent antifungal effects against planktonic and biofilm forms of Candida spp.: an in vitro and in silico study.
Sari S; Koçak E; Kart D; Özdemir Z; Acar MF; Sayoğlu B; Karakurt A; Dalkara S
Int Microbiol; 2021 Jan; 24(1):93-102. PubMed ID: 32889579
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening.
Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
Eur J Med Chem; 2019 Oct; 179():634-648. PubMed ID: 31279296
[TBL] [Abstract][Full Text] [Related]
3. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity of β-lapachone against azole-resistant
da Silva CR; S Campos R; de A Neto JB; Sampaio LS; do Nascimento FB; do Av Sá LG; Cândido TM; Magalhães HI; da Cruz EH; da Silva Júnior EN; de Moraes MO; Cavalcanti BC; Silva J; Marinho ES; Júnior HV
Future Microbiol; 2020 Oct; 15():1543-1554. PubMed ID: 33215521
[No Abstract] [Full Text] [Related]
5. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
[TBL] [Abstract][Full Text] [Related]
7. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Brilhante RSN; Bittencourt PV; de Souza Collares Castelo-Branco D; de Melo Guedes GM; de Oliveira JS; Alencar LP; de Aguiar Cordeiro R; Pinheiro M; Nogueira-Filho EF; de Aquino Pereira-Neto W; Sidrim JJC; Rocha MFG
Vet Ophthalmol; 2017 Nov; 20(6):539-546. PubMed ID: 28417524
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibitory activities of magnolol against
Zhou P; Fu J; Hua H; Liu X
Drug Des Devel Ther; 2017; 11():2653-2661. PubMed ID: 28919715
[No Abstract] [Full Text] [Related]
9. Evaluation of the antifungal activity
Holanda MA; da Silva CR; de A Neto JB; do Av Sá LG; do Nascimento FB; Barroso DD; da Silva LJ; Cândido TM; Leitão AC; Barbosa AD; de Moraes MO; Cc B; Júnior HVN
Future Microbiol; 2021 Jan; 16(2):71-81. PubMed ID: 33459560
[No Abstract] [Full Text] [Related]
10. New miconazole-based azoles derived from eugenol show activity against Candida spp. and Cryptococcus gattii by inhibiting the fungal ergosterol biosynthesis.
Campos Péret VA; Reis RCFM; Braga SFP; Benedetti MD; Caldas IS; Carvalho DT; Santana LFA; Johann S; Souza TB
Eur J Med Chem; 2023 Aug; 256():115436. PubMed ID: 37146343
[TBL] [Abstract][Full Text] [Related]
11. Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of
Eldesouky HE; Lanman NA; Hazbun TR; Seleem MN
Virulence; 2020 Dec; 11(1):1466-1481. PubMed ID: 33100149
[TBL] [Abstract][Full Text] [Related]
12. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effects of aureobasidin A on Candida planktonic and biofilm cells.
Tan HW; Tay ST
Mycoses; 2013 Mar; 56(2):150-6. PubMed ID: 22882276
[TBL] [Abstract][Full Text] [Related]
14. Diclofenac exhibits synergism with azoles against planktonic cells and biofilms of
Brilhante RSN; Brasil JA; Oliveira JS; Pereira VS; Pereira-Neto WA; Sidrim JJC; Rocha MFG
Biofouling; 2020 May; 36(5):528-536. PubMed ID: 32546021
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal activity of cassia fistula extracts against fluconazole resistant strains of Candida species from HIV patients.
Sony P; Kalyani M; Jeyakumari D; Kannan I; Sukumar RG
J Mycol Med; 2018 Mar; 28(1):193-200. PubMed ID: 28838629
[TBL] [Abstract][Full Text] [Related]
16. Antifungal screening and in silico mechanistic studies of an in-house azole library.
Sari S; Kart D; Sabuncuoğlu S; Doğan İS; Özdemir Z; Bozbey İ; Gencel M; Eşsiz Ş; Reynisson J; Karakurt A; Saraç S; Dalkara S
Chem Biol Drug Des; 2019 Sep; 94(5):1944-1955. PubMed ID: 31260179
[TBL] [Abstract][Full Text] [Related]
17. Miltefosine inhibits Candida albicans and non-albicans Candida spp. biofilms and impairs the dispersion of infectious cells.
Vila T; Ishida K; Seabra SH; Rozental S
Int J Antimicrob Agents; 2016 Nov; 48(5):512-520. PubMed ID: 27667564
[TBL] [Abstract][Full Text] [Related]
18. New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies.
Doğan İS; Saraç S; Sari S; Kart D; Eşsiz Gökhan Ş; Vural İ; Dalkara S
Eur J Med Chem; 2017 Apr; 130():124-138. PubMed ID: 28242548
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.
Vila TV; Chaturvedi AK; Rozental S; Lopez-Ribot JL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7611-20. PubMed ID: 26416861
[TBL] [Abstract][Full Text] [Related]
20. In vitro Antifungal Effects of Berberine Against
Xie Y; Liu X; Zhou P
Drug Des Devel Ther; 2020; 14():87-101. PubMed ID: 32021094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
